{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:30:02Z","timestamp":1767951002577,"version":"3.49.0"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disorder caused by fumarylacetoacetate hydrolase deficiency, leading to the accumulation of toxic metabolites such as fumarylacetoacetate (FAA) and succinylacetone (SA). We report an 11-year-old boy with poorly controlled HT1 who presented with a severe neurovisceral crisis after suboptimal adherence to nitisinone (NTBC) therapy, characterized by abdominal pain, hypertension, paralytic ileus, seizures, and profound hyponatremia. Biochemical evaluation revealed markedly elevated urinary \u03b4-aminolevulinic acid (ALA), consistent with a porphyria-like metabolic decompensation, together with inappropriately increased plasma copeptin in the setting of hypotonic hyponatremia and clinical euvolemia, fulfilling diagnostic criteria for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Optimization of NTBC therapy combined with tailored fluid management resulted in complete clinical and biochemical recovery. This case supports a pathophysiological link between acute disruption of the heme\u2013porphyrin pathway and inappropriate antidiuretic hormone secretion. In HT1, this susceptibility may be further amplified by FAA- and SA-mediated oxidative stress, mitochondrial dysfunction, and heme depletion, with an additional contribution from SA-associated renal tubular impairment. Overall, our findings underscore SIADH as a potentially underrecognized cause of acute hyponatremia in HT1 and highlight the importance of strict NTBC adherence and early monitoring of urinary ALA during metabolic decompensation.<\/jats:p>","DOI":"10.3390\/ijms27020660","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:09:06Z","timestamp":1767946146000},"page":"660","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SIADH as an Underrecognized Manifestation of Porphyria-like Crises in Hereditary Tyrosinemia Type 1: Clinical and Pathophysiological Insights"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8103-5417","authenticated-orcid":false,"given":"Eleonora","family":"Saraceno","sequence":"first","affiliation":[{"name":"Department of Public Health and Pediatrics, Postgraduate School of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"},{"name":"Department of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Serra","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatrics, Postgraduate School of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"},{"name":"Pediatric Emergency Department, Regina Margherita Children\u2019s Hospital, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7519-9849","authenticated-orcid":false,"given":"Beatrice","family":"Bracci","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatrics, Postgraduate School of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"},{"name":"Department of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Pagliardini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Pinon","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Unit, Regina Margherita Children\u2019s Hospital, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-8958","authenticated-orcid":false,"given":"Gerdi","family":"Tuli","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology Unit, Regina Margherita Children\u2019s Hospital, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Versace","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department, Regina Margherita Children\u2019s Hospital, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bondone","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department, Regina Margherita Children\u2019s Hospital, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-350X","authenticated-orcid":false,"given":"Marco","family":"Spada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Regina Margherita Children\u2019s Hospital, University of Torino, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/gim.2017.101","article-title":"Diagnosis and Treatment of Tyrosinemia Type I: A US and Canadian Consensus Group Review and Recommendations","volume":"19","author":"Chinsky","year":"2017","journal-title":"Genet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-55780-9_2","article-title":"Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1","volume":"959","author":"Morrow","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(21)00092-9","article-title":"Long-Term Safety and Outcomes in Hereditary Tyrosinaemia Type 1 with Nitisinone Treatment: A 15-Year Non-Interventional, Multicentre Study","volume":"9","author":"Spiekerkoetter","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13023-021-01879-1","article-title":"Treatment Adherence in Tyrosinemia Type 1 Patients","volume":"16","author":"Andrade","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199002153220704","article-title":"Neurologic Crises in Hereditary Tyrosinemia","volume":"322","author":"Mitchell","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e70089","DOI":"10.1002\/jimd.70089","article-title":"Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines","volume":"48","author":"Kuypers","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: A Review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1007\/s10545-008-0807-z","article-title":"Severe Neurological Crisis in a Patient with Hereditary Tyrosinaemia Type I after Interruption of NTBC Treatment","volume":"31","author":"Schlump","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endrev\/bnad010","article-title":"Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management","volume":"44","author":"Warren","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.21037\/atm-20-1529","article-title":"Management of Hyponatremia Associated with Acute Porphyria\u2014Proposal for the Use of Tolvaptan","volume":"8","author":"Solares","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11011-016-9833-y","article-title":"Tyrosinemia Type 1 and Irreversible Neurologic Crisis after One Month Discontinuation of Nitisone","volume":"31","author":"Horoz","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.18295\/squmj.2021.21.02.023","article-title":"Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Uncontrolled Tyrosinaemia Type 1","volume":"21","year":"2021","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ricci, A., Di Pierro, E., Marcacci, M., and Ventura, P. (2021). Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias. Diagnostics, 11.","DOI":"10.3390\/diagnostics11122205"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, T.L., Benvegn\u00fa, D.M., Bonfanti, G., Frediani, A.V., and Rocha, J.B.T. (2009). Delta-ALA-D Activity Is a Reliable Marker for Oxidative Stress in Bone Marrow Transplant Patients. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-138"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.27232","article-title":"Porphyric Neuropathy","volume":"64","author":"Caress","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mecawi, A.S., Varanda, W.A., and da Silva, M.P. (2022). Osmoregulation and the Hypothalamic Supraoptic Nucleus: From Genes to Functions. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.887779"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12640-018-9962-7","article-title":"Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response","volume":"36","author":"Bordt","year":"2019","journal-title":"Neurotox. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"R1815","DOI":"10.1152\/ajpregu.2001.280.6.R1815","article-title":"NO Inhibits Supraoptic Oxytocin and Vasopressin Neurons via Activation of GABAergic Synaptic Inputs","volume":"280","author":"Stern","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2826.2011.02249.x","article-title":"Enhanced Expression of Heme Oxygenase-1 and Carbon Monoxide Excitatory Effects in Oxytocin and Vasopressin Neurones during Water Deprivation","volume":"24","author":"Reis","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Soladogun, A.S., and Zhang, L. (2024). The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis. Antioxidants, 13.","DOI":"10.3390\/antiox13121441"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.niox.2019.04.007","article-title":"Site and Mechanism of Uncoupling of Nitric-Oxide Synthase: Uncoupling by Monomerization and Other Misconceptions","volume":"89","author":"Gebhart","year":"2019","journal-title":"Nitric Oxide"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mascarenhas, D., Mohammadi, A., Higazy, R., Ivanovska, J., Gauda, E., and Jasani, B. (2024). L-Citrulline in Neonates: From Bench to Bed Side. Children, 12.","DOI":"10.3390\/children12010042"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Duvigneau, J.C., Esterbauer, H., and Kozlov, A.V. (2019). Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways. Antioxidants, 8.","DOI":"10.3390\/antiox8100475"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI110809","article-title":"Hereditary Tyrosinemia and the Heme Biosynthetic Pathway. Profound Inhibition of Delta-Aminolevulinic Acid Dehydratase Activity by Succinylacetone","volume":"71","author":"Sassa","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1203\/01.pdr.0000198810.57642.b4","article-title":"Kidneys of Mice with Hereditary Tyrosinemia Type I Are Extremely Sensitive to Cytotoxicity","volume":"59","author":"Jacobs","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3181\/00379727-196-43211","article-title":"Succinylacetone Effects on Renal Tubular Phosphate Metabolism: A Model for Experimental Renal Fanconi Syndrome","volume":"196","author":"Roth","year":"1991","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_27","first-page":"e35574","article-title":"Clinical Approach to Euvolemic Hyponatremia","volume":"15","author":"Reddy","year":"2023","journal-title":"Cureus"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/660\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:10:43Z","timestamp":1767946243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020660"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020660","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}